Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Clinical trial NCT02066402 · COMPLETED
Trial details
- NCT number
- NCT02066402
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-04
- Primary completion
- 2016-03-06
- Enrollment
- 598
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.